カテゴリー： 世界, 医療/バイオ, LP Information

世界の視神経障害治療市場予測 2023年-2029年

【英語タイトル】Global Optic Neuropathy Treatment Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00222）・商品コード：LP23DC00222
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の視神経障害治療市場」は、過去の販売実績から2022年の世界の視神経障害治療の総販売量を検討し、2023年から2029年の予測される視神経障害治療の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の視神経障害治療の市場規模を掲載し、XXX百万米ドル規模の世界の視神経障害治療市場の詳細な分析を提供します。本インサイトレポートは、世界の視神経障害治療業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の視神経障害治療市場における各社の独自のポジションをより深く理解するために、視神経障害治療製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の視神経障害治療市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。視神経障害治療の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。視神経障害治療の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。視神経障害治療のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

視神経障害治療の世界主要メーカーとしては、AbbVie Inc.、 Eli Lilly and Company、 GSK Plc.、 Pfizer Inc.、 Teva Pharmaceutical Industries Ltd.、 Bausch Health Companies Inc.、 F. Hoffmann-La Roche AG、 Bayer AG、 Sanofi S.A、 Bristol-Myers Squibb Companyなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の視神経障害治療市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では視神経障害治療市場をセグメンテーションし、種類別 (経口、注射)、用途別 (病院薬局、オンライン薬局、小売薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：経口、注射

・用途別区分：病院薬局、オンライン薬局、小売薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の視神経障害治療市場の10年間の市場状況・展望は？
・世界および地域別に見た視神経障害治療市場成長の要因は何か？
・視神経障害治療の市場機会はエンドマーケットの規模によってどのように変化するのか？
・視神経障害治療のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：視神経障害治療の年間販売量2018-2029、地域別現状・将来分析
・視神経障害治療の種類別セグメント：経口、注射
・視神経障害治療の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・視神経障害治療の用途別セグメント：病院薬局、オンライン薬局、小売薬局
・視神経障害治療の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の視神経障害治療市場
・企業別のグローバル視神経障害治療市場データ：2018-2023年の年間販売量、市場シェア
・企業別の視神経障害治療の年間売上：2018-2023年の売上、市場シェア
・企業別の視神経障害治療販売価格
・主要企業の視神経障害治療生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

視神経障害治療の地域別レビュー
・地域別の視神経障害治療市場規模2018-2023：年間販売量、売上
・主要国別の視神経障害治療市場規模2018-2023：年間販売量、売上
・南北アメリカの視神経障害治療販売の成長
・アジア太平洋の視神経障害治療販売の成長
・ヨーロッパの視神経障害治療販売の成長
・中東・アフリカの視神経障害治療販売の成長

南北アメリカ市場
・南北アメリカの国別の視神経障害治療販売量、売上（2018-2023）
・南北アメリカの視神経障害治療の種類別販売量
・南北アメリカの視神経障害治療の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の視神経障害治療販売量、売上（2018-2023）
・アジア太平洋の視神経障害治療の種類別販売量
・アジア太平洋の視神経障害治療の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の視神経障害治療販売量、売上（2018-2023）
・ヨーロッパの視神経障害治療の種類別販売量
・ヨーロッパの視神経障害治療の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の視神経障害治療販売量、売上（2018-2023）
・中東・アフリカの視神経障害治療の種類別販売量
・中東・アフリカの視神経障害治療の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・視神経障害治療の製造コスト構造分析
・視神経障害治療の製造プロセス分析
・視神経障害治療の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・視神経障害治療の主要なグローバル販売業者
・視神経障害治療の主要なグローバル顧客

地域別の視神経障害治療市場予測レビュー
・地域別の視神経障害治療市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・視神経障害治療の種類別市場規模予測
・視神経障害治療の用途別市場規模予測

主要企業分析
AbbVie Inc.、 Eli Lilly and Company、 GSK Plc.、 Pfizer Inc.、 Teva Pharmaceutical Industries Ltd.、 Bausch Health Companies Inc.、 F. Hoffmann-La Roche AG、 Bayer AG、 Sanofi S.A、 Bristol-Myers Squibb Company
・企業情報
・視神経障害治療製品
・視神経障害治療販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Optic Neuropathy Treatment market size is projected to grow from US$ 4006.2 million in 2022 to US$ 5707.8 million in 2029; it is expected to grow at a CAGR of 5.2% from 2023 to 2029.
United States market for Optic Neuropathy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Optic Neuropathy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Optic Neuropathy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Optic Neuropathy Treatment players cover AbbVie Inc., Eli Lilly and Company, GSK Plc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., F. Hoffmann-La Roche AG, Bayer AG and Sanofi S.A, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Optic neuropathy is a condition that affects the optic nerve, which is responsible for transmitting visual information from the eyes to the brain. This condition can result in vision loss, blurred vision, and other symptoms.
LPI (LP Information)’ newest research report, the “Optic Neuropathy Treatment Industry Forecast” looks at past sales and reviews total world Optic Neuropathy Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Optic Neuropathy Treatment sales for 2023 through 2029. With Optic Neuropathy Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Optic Neuropathy Treatment industry.
This Insight Report provides a comprehensive analysis of the global Optic Neuropathy Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Optic Neuropathy Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Optic Neuropathy Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Optic Neuropathy Treatment and breaks down the forecast by route, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Optic Neuropathy Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Optic Neuropathy Treatment market by product route, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by route
Oral
Injectable
Segmentation by application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
AbbVie Inc.
Eli Lilly and Company
GSK Plc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Bausch Health Companies Inc.
F. Hoffmann-La Roche AG
Bayer AG
Sanofi S.A
Bristol-Myers Squibb Company
Key Questions Addressed in this Report
What is the 10-year outlook for the global Optic Neuropathy Treatment market?
What factors are driving Optic Neuropathy Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Optic Neuropathy Treatment market opportunities vary by end market size?
How does Optic Neuropathy Treatment break out route, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Optic Neuropathy Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Optic Neuropathy Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Optic Neuropathy Treatment by Country/Region, 2018, 2022 & 2029
2.2 Optic Neuropathy Treatment Segment by Route
2.2.1 Oral
2.2.2 Injectable
2.3 Optic Neuropathy Treatment Sales by Route
2.3.1 Global Optic Neuropathy Treatment Sales Market Share by Route (2018-2023)
2.3.2 Global Optic Neuropathy Treatment Revenue and Market Share by Route (2018-2023)
2.3.3 Global Optic Neuropathy Treatment Sale Price by Route (2018-2023)
2.4 Optic Neuropathy Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Optic Neuropathy Treatment Sales by Application
2.5.1 Global Optic Neuropathy Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Optic Neuropathy Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Optic Neuropathy Treatment Sale Price by Application (2018-2023)
3 Global Optic Neuropathy Treatment by Company
3.1 Global Optic Neuropathy Treatment Breakdown Data by Company
3.1.1 Global Optic Neuropathy Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Optic Neuropathy Treatment Sales Market Share by Company (2018-2023)
3.2 Global Optic Neuropathy Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Optic Neuropathy Treatment Revenue by Company (2018-2023)
3.2.2 Global Optic Neuropathy Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Optic Neuropathy Treatment Sale Price by Company
3.4 Key Manufacturers Optic Neuropathy Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Optic Neuropathy Treatment Product Location Distribution
3.4.2 Players Optic Neuropathy Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Optic Neuropathy Treatment by Geographic Region
4.1 World Historic Optic Neuropathy Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Optic Neuropathy Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Optic Neuropathy Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Optic Neuropathy Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Optic Neuropathy Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Optic Neuropathy Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Optic Neuropathy Treatment Sales Growth
4.4 APAC Optic Neuropathy Treatment Sales Growth
4.5 Europe Optic Neuropathy Treatment Sales Growth
4.6 Middle East & Africa Optic Neuropathy Treatment Sales Growth
5 Americas
5.1 Americas Optic Neuropathy Treatment Sales by Country
5.1.1 Americas Optic Neuropathy Treatment Sales by Country (2018-2023)
5.1.2 Americas Optic Neuropathy Treatment Revenue by Country (2018-2023)
5.2 Americas Optic Neuropathy Treatment Sales by Route
5.3 Americas Optic Neuropathy Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Optic Neuropathy Treatment Sales by Region
6.1.1 APAC Optic Neuropathy Treatment Sales by Region (2018-2023)
6.1.2 APAC Optic Neuropathy Treatment Revenue by Region (2018-2023)
6.2 APAC Optic Neuropathy Treatment Sales by Route
6.3 APAC Optic Neuropathy Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Optic Neuropathy Treatment by Country
7.1.1 Europe Optic Neuropathy Treatment Sales by Country (2018-2023)
7.1.2 Europe Optic Neuropathy Treatment Revenue by Country (2018-2023)
7.2 Europe Optic Neuropathy Treatment Sales by Route
7.3 Europe Optic Neuropathy Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Optic Neuropathy Treatment by Country
8.1.1 Middle East & Africa Optic Neuropathy Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Optic Neuropathy Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Optic Neuropathy Treatment Sales by Route
8.3 Middle East & Africa Optic Neuropathy Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Optic Neuropathy Treatment
10.3 Manufacturing Process Analysis of Optic Neuropathy Treatment
10.4 Industry Chain Structure of Optic Neuropathy Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Optic Neuropathy Treatment Distributors
11.3 Optic Neuropathy Treatment Customer
12 World Forecast Review for Optic Neuropathy Treatment by Geographic Region
12.1 Global Optic Neuropathy Treatment Market Size Forecast by Region
12.1.1 Global Optic Neuropathy Treatment Forecast by Region (2024-2029)
12.1.2 Global Optic Neuropathy Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Optic Neuropathy Treatment Forecast by Route
12.7 Global Optic Neuropathy Treatment Forecast by Application
13 Key Players Analysis
13.1 AbbVie Inc.
13.1.1 AbbVie Inc. Company Information
13.1.2 AbbVie Inc. Optic Neuropathy Treatment Product Portfolios and Specifications
13.1.3 AbbVie Inc. Optic Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AbbVie Inc. Main Business Overview
13.1.5 AbbVie Inc. Latest Developments
13.2 Eli Lilly and Company
13.2.1 Eli Lilly and Company Company Information
13.2.2 Eli Lilly and Company Optic Neuropathy Treatment Product Portfolios and Specifications
13.2.3 Eli Lilly and Company Optic Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Eli Lilly and Company Main Business Overview
13.2.5 Eli Lilly and Company Latest Developments
13.3 GSK Plc.
13.3.1 GSK Plc. Company Information
13.3.2 GSK Plc. Optic Neuropathy Treatment Product Portfolios and Specifications
13.3.3 GSK Plc. Optic Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Plc. Main Business Overview
13.3.5 GSK Plc. Latest Developments
13.4 Pfizer Inc.
13.4.1 Pfizer Inc. Company Information
13.4.2 Pfizer Inc. Optic Neuropathy Treatment Product Portfolios and Specifications
13.4.3 Pfizer Inc. Optic Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Inc. Main Business Overview
13.4.5 Pfizer Inc. Latest Developments
13.5 Teva Pharmaceutical Industries Ltd.
13.5.1 Teva Pharmaceutical Industries Ltd. Company Information
13.5.2 Teva Pharmaceutical Industries Ltd. Optic Neuropathy Treatment Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Industries Ltd. Optic Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.5.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.6 Bausch Health Companies Inc.
13.6.1 Bausch Health Companies Inc. Company Information
13.6.2 Bausch Health Companies Inc. Optic Neuropathy Treatment Product Portfolios and Specifications
13.6.3 Bausch Health Companies Inc. Optic Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bausch Health Companies Inc. Main Business Overview
13.6.5 Bausch Health Companies Inc. Latest Developments
13.7 F. Hoffmann-La Roche AG
13.7.1 F. Hoffmann-La Roche AG Company Information
13.7.2 F. Hoffmann-La Roche AG Optic Neuropathy Treatment Product Portfolios and Specifications
13.7.3 F. Hoffmann-La Roche AG Optic Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 F. Hoffmann-La Roche AG Main Business Overview
13.7.5 F. Hoffmann-La Roche AG Latest Developments
13.8 Bayer AG
13.8.1 Bayer AG Company Information
13.8.2 Bayer AG Optic Neuropathy Treatment Product Portfolios and Specifications
13.8.3 Bayer AG Optic Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bayer AG Main Business Overview
13.8.5 Bayer AG Latest Developments
13.9 Sanofi S.A
13.9.1 Sanofi S.A Company Information
13.9.2 Sanofi S.A Optic Neuropathy Treatment Product Portfolios and Specifications
13.9.3 Sanofi S.A Optic Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sanofi S.A Main Business Overview
13.9.5 Sanofi S.A Latest Developments
13.10 Bristol-Myers Squibb Company
13.10.1 Bristol-Myers Squibb Company Company Information
13.10.2 Bristol-Myers Squibb Company Optic Neuropathy Treatment Product Portfolios and Specifications
13.10.3 Bristol-Myers Squibb Company Optic Neuropathy Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Bristol-Myers Squibb Company Main Business Overview
13.10.5 Bristol-Myers Squibb Company Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Optic Neuropathy Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Optic Neuropathy Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injectable
Table 5. Global Optic Neuropathy Treatment Sales by Route (2018-2023) & (K Units)
Table 6. Global Optic Neuropathy Treatment Sales Market Share by Route (2018-2023)
Table 7. Global Optic Neuropathy Treatment Revenue by Route (2018-2023) & ($ million)
Table 8. Global Optic Neuropathy Treatment Revenue Market Share by Route (2018-2023)
Table 9. Global Optic Neuropathy Treatment Sale Price by Route (2018-2023) & (US$/Unit)
Table 10. Global Optic Neuropathy Treatment Sales by Application (2018-2023) & (K Units)
Table 11. Global Optic Neuropathy Treatment Sales Market Share by Application (2018-2023)
Table 12. Global Optic Neuropathy Treatment Revenue by Application (2018-2023)
Table 13. Global Optic Neuropathy Treatment Revenue Market Share by Application (2018-2023)
Table 14. Global Optic Neuropathy Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Optic Neuropathy Treatment Sales by Company (2018-2023) & (K Units)
Table 16. Global Optic Neuropathy Treatment Sales Market Share by Company (2018-2023)
Table 17. Global Optic Neuropathy Treatment Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Optic Neuropathy Treatment Revenue Market Share by Company (2018-2023)
Table 19. Global Optic Neuropathy Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Optic Neuropathy Treatment Producing Area Distribution and Sales Area
Table 21. Players Optic Neuropathy Treatment Products Offered
Table 22. Optic Neuropathy Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Optic Neuropathy Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Optic Neuropathy Treatment Sales Market Share Geographic Region (2018-2023)
Table 27. Global Optic Neuropathy Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Optic Neuropathy Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Optic Neuropathy Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Optic Neuropathy Treatment Sales Market Share by Country/Region (2018-2023)
Table 31. Global Optic Neuropathy Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Optic Neuropathy Treatment Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Optic Neuropathy Treatment Sales by Country (2018-2023) & (K Units)
Table 34. Americas Optic Neuropathy Treatment Sales Market Share by Country (2018-2023)
Table 35. Americas Optic Neuropathy Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Optic Neuropathy Treatment Revenue Market Share by Country (2018-2023)
Table 37. Americas Optic Neuropathy Treatment Sales by Type (2018-2023) & (K Units)
Table 38. Americas Optic Neuropathy Treatment Sales by Application (2018-2023) & (K Units)
Table 39. APAC Optic Neuropathy Treatment Sales by Region (2018-2023) & (K Units)
Table 40. APAC Optic Neuropathy Treatment Sales Market Share by Region (2018-2023)
Table 41. APAC Optic Neuropathy Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Optic Neuropathy Treatment Revenue Market Share by Region (2018-2023)
Table 43. APAC Optic Neuropathy Treatment Sales by Route (2018-2023) & (K Units)
Table 44. APAC Optic Neuropathy Treatment Sales by Application (2018-2023) & (K Units)
Table 45. Europe Optic Neuropathy Treatment Sales by Country (2018-2023) & (K Units)
Table 46. Europe Optic Neuropathy Treatment Sales Market Share by Country (2018-2023)
Table 47. Europe Optic Neuropathy Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Optic Neuropathy Treatment Revenue Market Share by Country (2018-2023)
Table 49. Europe Optic Neuropathy Treatment Sales by Type (2018-2023) & (K Units)
Table 50. Europe Optic Neuropathy Treatment Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Optic Neuropathy Treatment Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Optic Neuropathy Treatment Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Optic Neuropathy Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Optic Neuropathy Treatment Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Optic Neuropathy Treatment Sales by Route (2018-2023) & (K Units)
Table 56. Middle East & Africa Optic Neuropathy Treatment Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Optic Neuropathy Treatment
Table 58. Key Market Challenges & Risks of Optic Neuropathy Treatment
Table 59. Key Industry Trends of Optic Neuropathy Treatment
Table 60. Optic Neuropathy Treatment Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Optic Neuropathy Treatment Distributors List
Table 63. Optic Neuropathy Treatment Customer List
Table 64. Global Optic Neuropathy Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Optic Neuropathy Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Optic Neuropathy Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Optic Neuropathy Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Optic Neuropathy Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Optic Neuropathy Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Optic Neuropathy Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Optic Neuropathy Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Optic Neuropathy Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Optic Neuropathy Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Optic Neuropathy Treatment Sales Forecast by Route (2024-2029) & (K Units)
Table 75. Global Optic Neuropathy Treatment Revenue Forecast by Route (2024-2029) & ($ Millions)
Table 76. Global Optic Neuropathy Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Optic Neuropathy Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. AbbVie Inc. Basic Information, Optic Neuropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 79. AbbVie Inc. Optic Neuropathy Treatment Product Portfolios and Specifications
Table 80. AbbVie Inc. Optic Neuropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. AbbVie Inc. Main Business
Table 82. AbbVie Inc. Latest Developments
Table 83. Eli Lilly and Company Basic Information, Optic Neuropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lilly and Company Optic Neuropathy Treatment Product Portfolios and Specifications
Table 85. Eli Lilly and Company Optic Neuropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Eli Lilly and Company Main Business
Table 87. Eli Lilly and Company Latest Developments
Table 88. GSK Plc. Basic Information, Optic Neuropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Plc. Optic Neuropathy Treatment Product Portfolios and Specifications
Table 90. GSK Plc. Optic Neuropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. GSK Plc. Main Business
Table 92. GSK Plc. Latest Developments
Table 93. Pfizer Inc. Basic Information, Optic Neuropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Inc. Optic Neuropathy Treatment Product Portfolios and Specifications
Table 95. Pfizer Inc. Optic Neuropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Inc. Main Business
Table 97. Pfizer Inc. Latest Developments
Table 98. Teva Pharmaceutical Industries Ltd. Basic Information, Optic Neuropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. Teva Pharmaceutical Industries Ltd. Optic Neuropathy Treatment Product Portfolios and Specifications
Table 100. Teva Pharmaceutical Industries Ltd. Optic Neuropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Teva Pharmaceutical Industries Ltd. Main Business
Table 102. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 103. Bausch Health Companies Inc. Basic Information, Optic Neuropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. Bausch Health Companies Inc. Optic Neuropathy Treatment Product Portfolios and Specifications
Table 105. Bausch Health Companies Inc. Optic Neuropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Bausch Health Companies Inc. Main Business
Table 107. Bausch Health Companies Inc. Latest Developments
Table 108. F. Hoffmann-La Roche AG Basic Information, Optic Neuropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. F. Hoffmann-La Roche AG Optic Neuropathy Treatment Product Portfolios and Specifications
Table 110. F. Hoffmann-La Roche AG Optic Neuropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. F. Hoffmann-La Roche AG Main Business
Table 112. F. Hoffmann-La Roche AG Latest Developments
Table 113. Bayer AG Basic Information, Optic Neuropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. Bayer AG Optic Neuropathy Treatment Product Portfolios and Specifications
Table 115. Bayer AG Optic Neuropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Bayer AG Main Business
Table 117. Bayer AG Latest Developments
Table 118. Sanofi S.A Basic Information, Optic Neuropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. Sanofi S.A Optic Neuropathy Treatment Product Portfolios and Specifications
Table 120. Sanofi S.A Optic Neuropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Sanofi S.A Main Business
Table 122. Sanofi S.A Latest Developments
Table 123. Bristol-Myers Squibb Company Basic Information, Optic Neuropathy Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. Bristol-Myers Squibb Company Optic Neuropathy Treatment Product Portfolios and Specifications
Table 125. Bristol-Myers Squibb Company Optic Neuropathy Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Bristol-Myers Squibb Company Main Business
Table 127. Bristol-Myers Squibb Company Latest Developments
List of Figures
Figure 1. Picture of Optic Neuropathy Treatment
Figure 2. Optic Neuropathy Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Optic Neuropathy Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Optic Neuropathy Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Optic Neuropathy Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injectable
Figure 11. Global Optic Neuropathy Treatment Sales Market Share by Route in 2022
Figure 12. Global Optic Neuropathy Treatment Revenue Market Share by Route (2018-2023)
Figure 13. Optic Neuropathy Treatment Consumed in Hospital Pharmacies
Figure 14. Global Optic Neuropathy Treatment Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 15. Optic Neuropathy Treatment Consumed in Online Pharmacies
Figure 16. Global Optic Neuropathy Treatment Market: Online Pharmacies (2018-2023) & (K Units)
Figure 17. Optic Neuropathy Treatment Consumed in Retail Pharmacies
Figure 18. Global Optic Neuropathy Treatment Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 19. Global Optic Neuropathy Treatment Sales Market Share by Application (2022)
Figure 20. Global Optic Neuropathy Treatment Revenue Market Share by Application in 2022
Figure 21. Optic Neuropathy Treatment Sales Market by Company in 2022 (K Units)
Figure 22. Global Optic Neuropathy Treatment Sales Market Share by Company in 2022
Figure 23. Optic Neuropathy Treatment Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Optic Neuropathy Treatment Revenue Market Share by Company in 2022
Figure 25. Global Optic Neuropathy Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Optic Neuropathy Treatment Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Optic Neuropathy Treatment Sales 2018-2023 (K Units)
Figure 28. Americas Optic Neuropathy Treatment Revenue 2018-2023 ($ Millions)
Figure 29. APAC Optic Neuropathy Treatment Sales 2018-2023 (K Units)
Figure 30. APAC Optic Neuropathy Treatment Revenue 2018-2023 ($ Millions)
Figure 31. Europe Optic Neuropathy Treatment Sales 2018-2023 (K Units)
Figure 32. Europe Optic Neuropathy Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Optic Neuropathy Treatment Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Optic Neuropathy Treatment Revenue 2018-2023 ($ Millions)
Figure 35. Americas Optic Neuropathy Treatment Sales Market Share by Country in 2022
Figure 36. Americas Optic Neuropathy Treatment Revenue Market Share by Country in 2022
Figure 37. Americas Optic Neuropathy Treatment Sales Market Share by Route (2018-2023)
Figure 38. Americas Optic Neuropathy Treatment Sales Market Share by Application (2018-2023)
Figure 39. United States Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Optic Neuropathy Treatment Sales Market Share by Region in 2022
Figure 44. APAC Optic Neuropathy Treatment Revenue Market Share by Regions in 2022
Figure 45. APAC Optic Neuropathy Treatment Sales Market Share by Route (2018-2023)
Figure 46. APAC Optic Neuropathy Treatment Sales Market Share by Application (2018-2023)
Figure 47. China Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Optic Neuropathy Treatment Sales Market Share by Country in 2022
Figure 55. Europe Optic Neuropathy Treatment Revenue Market Share by Country in 2022
Figure 56. Europe Optic Neuropathy Treatment Sales Market Share by Route (2018-2023)
Figure 57. Europe Optic Neuropathy Treatment Sales Market Share by Application (2018-2023)
Figure 58. Germany Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Optic Neuropathy Treatment Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Optic Neuropathy Treatment Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Optic Neuropathy Treatment Sales Market Share by Route (2018-2023)
Figure 66. Middle East & Africa Optic Neuropathy Treatment Sales Market Share by Application (2018-2023)
Figure 67. Egypt Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Optic Neuropathy Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Optic Neuropathy Treatment in 2022
Figure 73. Manufacturing Process Analysis of Optic Neuropathy Treatment
Figure 74. Industry Chain Structure of Optic Neuropathy Treatment
Figure 75. Channels of Distribution
Figure 76. Global Optic Neuropathy Treatment Sales Market Forecast by Region (2024-2029)
Figure 77. Global Optic Neuropathy Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Optic Neuropathy Treatment Sales Market Share Forecast by Route (2024-2029)
Figure 79. Global Optic Neuropathy Treatment Revenue Market Share Forecast by Route (2024-2029)
Figure 80. Global Optic Neuropathy Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Optic Neuropathy Treatment Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の視神経障害治療市場予測 2023年-2029年] (コード：LP23DC00222)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の視神経障害治療市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の肢先端脳梁症候群治療市場予測 2023年-2029年
  • 世界の胆道がん（BTC）治療市場予測 2023年-2029年
  • 世界の獣医用光ファイバー内視鏡市場予測 2023年-2029年
  • 世界の可動式光ファイバー酸素計市場予測 2023年-2029年
  • 世界の可動式光ファイバー酸素計市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆